Hernandez Luciana, Bottini Enriqueta, Cadona Jimena, Cacciato Claudio, Monteavaro Cristina, Bustamante Ana, Sanso Andrea Mariel
Laboratorio de Inmunoquímica y Biotecnología, CIVETAN (CONICET), Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires (UNCPBA), Tandil, Argentina.
Laboratorio de Microbiología Clínica y Experimental, CIVETAN (CONICET), Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires (UNCPBA), Tandil, Argentina.
Front Cell Infect Microbiol. 2021 Apr 30;11:647324. doi: 10.3389/fcimb.2021.647324. eCollection 2021.
is a pathogen-associated to bovine mastitis, a health disorder responsible for significant economic losses in the dairy industry. Antimicrobial therapy remains the main strategy for the control of this bacterium in dairy herds and human In order to get insight on molecular characteristics of strains circulating among Argentinean cattle with mastitis, we received 1500 samples from 56 dairy farms between 2016 and 2019. We recovered 56 isolates and characterized them in relation to serotypes, virulence genes, and antimicrobial susceptibility. Serotypes III and II were the most prevalent ones (46% and 41%, respectively), followed by Ia (7%). In relation to the 13 virulence genes screened in this study, the genes , and PI-2b were present in all the isolates, meanwhile, , , and were detected in different frequencies, 36%, 96%, and 59%, respectively. On the other hand, , PI-1, PI-2a, and genes could not be detected in any of the isolates. Disk diffusion method against a panel of eight antimicrobial agents showed an important number of strains resistant simultaneously to five antibiotics. We also detected several resistance-encoding genes, , and (9%, 50%, 32%, 32%, and 5%, respectively). The results here presented are the first molecular data on isolates causing bovine mastitis in Argentina and provide a foundation for the development of diagnostic, prophylactic, and therapeutic methods, including the perspective of a vaccine.